St. John’s wort

Common name: St. John’s wort
Other names: Saint John’s wort
Latin name: Hypericum perforatum
Affinities: Nervous system, digestive system
Actions: Nervine tonic, nervine trophorestorative, analgesic, antidepressant
Specific indications: Sharp shooting pains, nervous debility, anxiety, depression, nerve damage
Diseases: Neuralgia(2), anxiety(3), depression(1*), seasonal effective disorder(3), sciatica(2), carpal tunnel syndrome(2)
Parts used: Flowers
Energetics: Warming, drying


Characteristics: St. John’s wort is a popular medicinal herb native to Europe and produces bright five-petaled yellow flowers (Benzie, 2011). The name comes from its flowering around St John’s Day (24th June). The Latin name Hypericum is derived from the Greek words hyper (above) and eikon (picture), in referral to the tradition of hanging plants over religious icons in the home during St. John’s Day to ward off evil.

History: The medical usage of St. John’s wort can be dated back to the ancient Greeks (Castleman, 2001). The Greek physician Pedanius Dioscorides (40–90 AD) recommended it externally for burns and internally as a diuretic, treatment for sciatica, and malaria. The Greeks and Romans believed that St. John’s wort protected them against evil spells and the Christians adopted this belief, burning the herb on bonfires to drive away evil. It continued to be used by herbalists in the 16th century and John Gerard (1545–1612) recommended it as a ‘remedy for deepe wounds’. America’s 19th century physicians, the Eclectics, considered St. John’s wort to have ‘undoubted power over the nervous and spinal cord’. It has become well known as an anti-depressant through scientific experimentation although traditionally was not really used in this way.

Current applications: St. John’s wort is one of the great tonic herbs of traditional Western herbalism and is particuarly suited to treating nerve pain and anxiety. David Hoffman in Holistic Herbal points out St. John’s wort has a sedative and pain reducing effect, which gives it a place in the treatment of neuralgia, anxiety, tension (Hoffman, 1988). He also mentions it will ease sciatica and rheumatic pains. It may be useful in carpal tunnel syndrome, head trauma injury, vulvodynia, peripheral neuropathy, phantom limb pain, and in other nerve injuries. David Winston recommends it for mild to moderate depression along with a sour stomach (Winston, 2007). It may be combined with lemon balm for a stronger mood elevating effect. Combines particularly well with the American skullcap as a nervine tonic.

Science: St. John’s wort is rich in flavonoids, compounds with anti-oxidant activity (Zou et al., 2004), and compounds such as hypericin which are anti-inflammatory (Sosa et al., 2007). Hyperforin is thought to be the major compound in St. John’s wort responsible for its anti-depressant affects and it may inhibit serotonin reuptake (Chatterjee et al., 1998). St. John’s wort has been well studied for treating depression, mainly in Europe, and the quality of the studies is often high (Szegedi et al., 2004; Laakmann et al., 1998; Woelk et al., 2000). However, the consistency of results is variable, this is likely due to variable hyperforin content of the hypericum extracts, differing doses, and clinical heterogeneity (Laakmann et al., 1998). However, the number of large, well-controlled studies with positive results against either anti-depressants or a placebo is very convincing. Studies also find St. John’s wort to be better tolerated than conventional drugs (Woelk et al., 2000).

Three recent reviews concluded St. John’s wort to be more effective than a placebo in treating depression with similar efficiency to mainstream anti-depressant drugs and fewer adverse effects (Ng et al., 2017; Maher et al., 2016; Apaydin et al., 2016). There is also preliminary evidence that St. John’s wort may help patients with neuropathic pain (Galeotti et al., 2010; Sindrup et al., 2001), more work needs to be done here with higher doses and larger group sizes as explained below.

Safety: High, but only when observing contradictions. St. John’s wort may interact with other anti-depressants (particularly the SSRIs) and enhance their effects potentially leading to serotonin syndrome (Dannawi et al., 2002).

St. John’s wort increases drug metabolism (Moore et al., 2000), therefore drugs taken together with St. John’s wort may become less effective. Close monitoring of patients is required with their physician while taking St. John’s wort with other medications.

St. John’s wort may increase sun sensitivity (Bove et al., 1998), so while taking St. John’s wort be very cautious about exposure to direct sunlight as you may get sun burnt much more easily.

St John’s wort should not be used at the same time as the drugs warfarin, digoxin, cyclosporine, indinavir and related anti-HIV drugs. Do not recommend using St John’s wort to a woman who using the contraceptive pill to prevent pregnancy.

Dosage: Dose of fresh tincture is 10-60 drops 2-3 times daily. For dried standardised extracts follow directions on the packaging, however, maximum studied doses of dried extract go up to 1800mg/day (Szegedi et al., 2005).

Form: The fresh tincture is the preferred form by herbalists, look for a deep red colour.

Scientific Summary

Research on models

Anti-oxidant activity: A study found St. John’s wort contains flavonoids with potent anti-oxidant abilities (Zou et al., 2004).

Anti-inflammatory activity: A study found hypericum extracts applied topically using in vivo model were anti-inflammatory (Sosa et al., 2007).

Anti-hyperalgesic activity: A study using an in vivo model found hypericum was effective at reducing neuropathic pain (Galeotti et al., 2010).

Research on humans

Depression: One study (n = 251, double blind placebo controlled) found hypericum extract taken three times a day superior to paroxetine taken once per day (Szegedi et al., 2005). Dose was 1800mg per day of hypericum extract.

Depression(II): Another study (n = 147, double blind placebo controlled) found extract standardised to 5% hyperforin was significantly better than a placebo in treating mild to moderate depression, while the 0.5% hyperforin extract performed similarly to a placebo. Dose was 300mg of hypericum standardised extract taken three times daily (Laakmann et al., 1998).

Depression(III): One other study (n = 157, double blind placebo controlled) found 250mg hypericum extract taken twice daily performed equivalent to 75mg of imipramine taken twice daily in patients with mild to moderate depression (Woelk et al., 2000). 3% of St. John’s wort patients withdrew because of adverse events compared to 16% that took imipramine.

Polyneuropathy: A study (n = 54, double blind placebo controlled) where patients took hypericum extract three times daily, each containing 900μg total hypericin, was not statistically significant for treating polyneuropathy. However, there was a clear trend towards reduced pain in the hypericum treated group compared to placebo (p = 0.05). While various p values in this study were not strongly significant, the trend was always in favour of St. John’s wort extract versus the placebo. By my calculation the dose used here was on the low side. Maximum studied doses for depression are 1800 mg/day hypericum extract which translates to 2160ug/day to 5040ug/day hypericin (Szegedi et al., 2005). The experiment requires repeating with a higher dose, or preferably, using a fresh tincture.


Apaydin, Eric A., et al. “A systematic review of St. John’s wort for major depressive disorder.” Systematic Reviews 5.1 (2016): 148.

Benzie, Iris FF, and Sissi Wachtel-Galor, eds. Herbal medicine: biomolecular and clinical aspects. CRC Press, 2011.

Bove, Geoffrey M. “Acute neuropathy after exposure to sun in a patient treated with St John’s Wort.” The Lancet 352.9134 (1998): 1121-1122.

Castleman, Michael. “The new healing herbs.” Bantam Book, New York (2001): 465-471.

Chatterjee, S. S., et al. “Hyperforin as a possible antidepressant component of hypericum extracts.” Life sciences 63.6 (1998): 499-510.

Dannawi, Moemen. “Possible serotonin syndrome after combination of buspirone and St John’s Wort.” JOURNAL OF PSYCHOPHARMACOLOGY-OXFORD- 16.4 (2002): 401-401.

Galeotti, Nicoletta, et al. “St. John’s Wort reduces neuropathic pain through a hypericin-mediated inhibition of the protein kinase C γ and ɛ activity.” Biochemical pharmacology 79.9 (2010): 1327-1336.

Hoffman, David. Holistic herbal. Element Books, 1988.

Laakmann, G., et al. “St. John’s wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.” Pharmacopsychiatry 31.S 1 (1998): 54-59.

Maher, Alicia Ruelaz, et al. “St. John’s Wort for Major Depressive Disorder: A Systematic Review.” Rand Health Quarterly 5.4 (2016).

Moore, Linda B., et al. “St. John’s wort induces hepatic drug metabolism through activation of the pregnane X receptor.” Proceedings of the National Academy of Sciences 97.13 (2000): 7500-7502.

Ng, Qin Xiang, Nandini Venkatanarayanan, and Collin Yih Xian Ho. “Clinical use of Hypericum perforatum (St John’s wort) in depression: A meta-analysis.” Journal of Affective Disorders 210 (2017): 211-221.

Sindrup, Søren H., et al. “St. John’s wort has no effect on pain in polyneuropathy.” Pain 91.3 (2001): 361-365.

Sosa, Silvio, et al. “Topical anti‐inflammatory activity of extracts and compounds from Hypericum perforatum L.” Journal of Pharmacy and Pharmacology 59.5 (2007): 703-709.

Szegedi, A., et al. “Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John’s wort): randomised controlled double blind non-inferiority trial versus paroxetine.” Bmj 330.7490 (2005): 503.

Winston, David, and Steven Maimes. Adaptogens: herbs for strength, stamina, and stress relief. Inner Traditions/Bear & Co, 2007.

Woelk, Helmut. “Comparison of St John’s wort and imipramine for treating depression: randomised controlled trial.” Bmj 321.7260 (2000): 536-539.

Zou, Yanping, Yanhua Lu, and Dongzhi Wei. “Antioxidant activity of a flavonoid-rich extract of Hypericum perforatum L. in vitro.” Journal of Agricultural and Food Chemistry 52.16 (2004): 5032-5039.